Navigation Links
Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
Date:6/18/2008

FORT LAUDERDALE, Fla., June 18 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a specialty pharmaceutical company, today announced that its wholly owned subsidiary, Kirk Pharmaceuticals, LLC (Kirk) during the past year has added Dollar General and K-Mart to their growing list of clients that includes Target, Walgreens, Family Dollar, HEB and many others. The products contracted for by these retailers are all over-the-counter (OTC) private label or "store brand" drugs.

"Kirk's new customers are the result of a successful ongoing total effort by our overall Kirk operation working with our sales team to grow our OTC private label business," stated Stephen Friedman, Kirk's acting Sr. VP of Marketing and Sales. "Our mission is to offer our customers a complete range of high-quality, competitively priced products in the large analgesic, cough, cold and laxative segments where store brands exceed 30% of their total respective category sales."

Friedman goes on to say that, "Kirk, as an organization, is highly committed to providing our customers their three most valued expectations: quality, price and customer service. We have made a Company-wide effort to build our customer service level to meet the high standard of service our customers require and deserve. The success of this effort is now being reflected in a growth of our private label sales and Company revenues. We appreciate these companies as valued customers and are very grateful for the confidence they have shown us. We believe that with a continuation of this effort we have the promise of even better results."

"We are most pleased with these important new customer relationships," commented Ronald Howard Lane, Ph.D., Synovics' Chairman and Chief Executive Officer. "It is most rewarding to see the outcome of the commitment and hard work of the Company's people being reflected in its customer service and potentially multi-million dollar orders from the
'/>"/>

SOURCE Synovics Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...nc. today announced a collaborative research agree... at evaluating EpiVax’s proprietary Tregitop...mental immune responses to certain drugs. In the c...x Tregitope technology will be evaluated for its e...ics. , (Vocus) December 2...
(Date:12/1/2009).... 1 Aethlon Medical, Inc...it will present at the LD MICRO Conference on Thur...uxe Hotel in Los Angeles. Aethlon Medical,s Chairm...te overview and will provide an update on the comp...Hemopurifier®, a first-in-class artificial ad...
(Date:12/1/2009)...na, Dec. 1 /PRNewswire-Asia-FirstCall/ -- China Sk...he Company") (Nasdaq: CSKI ), a leading,fully int...ucing,over-the-counter drugs in the People,s Repub...pany has engaged Guangdong Mediacy Kind Medical De... its exclusive sales agent for the,Company,s AMI D...
(Date:12/1/2009)...wswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bull...d, biopharmaceutical company developing human vacc...iciency Virus) and other infectious agents, today ...oday is the 21st World AIDS Day and as we remember...HIV/AIDS pandemic, we remain focused and devoted t...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
... Calif., Oct. 29 Sangamo,BioSciences, Inc. (Nasda...cial results and accomplishments., For the third ... a,consolidated net loss of $6.3 million, or $0.15..., or $0.11 per share, for the same period in 2007....ash equivalents and,investments of $59.5 million. ...
...Mass., Oct. 29 Aware, Inc. (Nasdaq:,AWRE), a lead...s software,announced today that its Board of Direc...inally authorized on August 28, 2007 to repurchase...o $5 million worth of shares of,the Company,s comm...cember,31, 2009 at prevailing market prices. The B...
...lion Net Revenues, $0.10 Net Income Per Share, SA...ies, Inc. (Nasdaq: VNUS ), a leading provider of ...nt of venous disease, today announced its,financia..., 2008., Net revenues for the third quarter of 20...7.5 million for the third quarter of 2007. Net,rev...
Other Biology Technology:Sangamo BioSciences Reports Third Quarter 2008 Financial Results 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 3Sangamo BioSciences Reports Third Quarter 2008 Financial Results 4Sangamo BioSciences Reports Third Quarter 2008 Financial Results 5Sangamo BioSciences Reports Third Quarter 2008 Financial Results 6Sangamo BioSciences Reports Third Quarter 2008 Financial Results 7Aware, Inc. Announces Extension of Stock Repurchase Plan 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 3VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 4VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 5VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 6VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 7VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 8VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 9VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 10
(Date:11/30/2009)...pings of gravy and dessert at the holiday table ar...ously thought. According to a new research report ... http://www.fasebj.org ), a diet that is high in f...timately cause our bodies to store too much fat. T... as the already difficult task of converting high-...
(Date:11/30/2009)...s available in German . , The DFG has appro...arch Centres as of 1 January 2010. This decision w...in Bonn. The new centres will initially be funded ...ition, 20 percent overhead funding for indirect co...ntres, research topics range from modern prosthese...
(Date:11/30/2009)...- The inaugural Global Conference on Systems & Ent... Washington, DC, focuses on the convergence of com...al importance to society. , The goal of the ...ivity around targeted complex systems, examined by...includes Critical Infrastructure Systems, includin...
Breaking Biology News(10 mins):Happy holidays from the groaning board; Western diets turn on fat genes 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Finesse Solutions Expands Into State of the Art Facility in San Jose CA USA 12606 1Aussie and Kiwi researchers make double MS genetic discovery 8821 1Aussie and Kiwi researchers make double MS genetic discovery 8821 2Symbia net Hotspot for Remote Access 48825 1Symbia net Hotspot for Remote Access 48825 2Symbia net Hotspot for Remote Access 48825 3
...sts from around the world will convene at the Univ... key findings from the most ambitious effort ever ...tants in the Arctic and determine how they contrib...way in the vast, climate-sensitive region. , The ...ARCAT was conducted most intensively during two th...
...ands, May 26, 2009 There are several risk factors...scular dementia. Based on an increasing number of ...deficiency, an article in the current issue of the...lliam B. Grant, PhD of the Sunlight, Nutrition, an...rther investigation of possible direct or indirect...
...sen sharply in developed countries in the wake of ...Europeans live with the condition. Foot problems a...for diabetics, who are at risk of serious complica...lood supply to their feet. Both conditions can lea... they get infected and become gangrenous, can lead...
Other Biology News:Spring agricultural fires have large impact on melting Arctic 2Spring agricultural fires have large impact on melting Arctic 3Is vitamin D deficiency linked to Alzheimer's disease and vascular dementia? 2Protective footwear for diabetics at a high-street price 2Protective footwear for diabetics at a high-street price 3
Amido Black 10B, CI 20470 from Research Organics, Inc.
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from GeneTex
Anti-Human Ig Lambda-chain Monoclonal Antibody, Unconjugated, Clone ICO-16 from Cell Sciences
Biology Products: